Raltegravir EP Impurity G & F Mixture

Product Description
CAT No.
ALN-R009009
CAS No.
NA
Mol. F.
C44H54F2N12O12
Mol. Wt.
981
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : Ethyl (E)-N-(2-((2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)amino)-2-oxoacetyl)acetohydrazonate compound with ethyl (Z)-N-(2-((2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)amino)-2-oxoacetyl)acetohydrazonate (1:1)
Smiles : O=C(C(NC(C)(C)C(N1C)=NC(C(NCC2=CC=C(F)C=C2)=O)=C(O)C1=O)=O)N/N=C(C)\OCC.CCO/C(C)=N/NC(C(NC(C)(C)C(N3C)=NC(C(NCC4=CC=C(F)C=C4)=O)=C(O)C3=O)=O)=O
Inchi : InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H2,11,12)
Technical Data
Reference
Development and validation of stability indicating RP-HPLC assay method of raltegravir in tablet dosage forms
By Shirisha, V.; Sairaju, B.; Illendula, Santhosh; Dutt, K. RajeswarnFrom World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(10), 668-692
Stability indicating reverse-phase high performance liquid chromatography method for the determination of raltegravir in bulk and pharmaceutical formulation
By Annapurna, Mukthinuthalapati Mathrusri; Teja, Gunnam Ravi; Hemchand, S.; Babu, R. Ravi Chandra – From International Journal of Green Pharmacy (2018), 12(1Suppl.), S177-S180
Development and validation of RP-HPLC method for determination of raltegravir and its impurities in bulk drug and dosage forms
By Balaji, M.; AppaRao, K. M. Ch.; Ramakrishna, K.; Srinivasarao, V. – From Pharma Science Monitor (2014), 5(3Suppl.1), 187-196, 10 pp.
RFQ